CD34 and acute myeloid leukemia: The primary objective of this retrospective study was to assess the relative efficacy of two TCD approaches, in vitro TCD using ATG, and ex vivo TCD with CD34 selection, and showed high OS and LFS with both approaches in patients with AML in CR1 transplanted with matched donors after a MAC regimen.